BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32495313)

  • 1. Obesity and Psoriatic Arthritis: A Narrative Review.
    Kumthekar A; Ogdie A
    Rheumatol Ther; 2020 Sep; 7(3):447-456. PubMed ID: 32495313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Mir-140 and leptin improve the accuracy of the differential diagnosis between psoriatic arthritis and rheumatoid arthritis: a case-control study.
    Cheleschi S; Tenti S; Bedogni G; Fioravanti A
    Transl Res; 2022 Jan; 239():18-34. PubMed ID: 34380068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management.
    Russolillo A; Iervolino S; Peluso R; Lupoli R; Di Minno A; Pappone N; Di Minno MN
    Rheumatology (Oxford); 2013 Jan; 52(1):62-7. PubMed ID: 22989426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
    Atzeni F; Gerratana E; Francesco Masala I; Bongiovanni S; Sarzi-Puttini P; Rodríguez-Carrio J
    Front Med (Lausanne); 2021; 8():735150. PubMed ID: 34527685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriatic arthritis and the association with cardiometabolic disease: a narrative review.
    Karmacharya P; Ogdie A; Eder L
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X21998279. PubMed ID: 33737966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of body mass index on treatment response of biologic/targeted-synthetic DMARDs in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. A systematic review.
    Gialouri CG; Pappa M; Evangelatos G; Nikiphorou E; Fragoulis GE
    Autoimmun Rev; 2023 Jul; 22(7):103357. PubMed ID: 37150489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IL-23 significantly decreased in obese patients with psoriatic arthritis six months after a structured weight loss intervention.
    Landgren AJ; Jonsson CA; Bilberg A; Eliasson B; Torres L; Dehlin M; Jacobsson LTH; Gjertsson I; Larsson I; Klingberg E
    Arthritis Res Ther; 2023 Jul; 25(1):131. PubMed ID: 37501212
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Larid G; Delwail A; Dalle T; Vasseur P; Silvain C; Jégou JF; Morel F; Lecron JC; Gervais E
    Front Immunol; 2022; 13():993363. PubMed ID: 36426370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of inflammatory biomarkers and disease activity with subclinical myocardial dysfunction in psoriatic arthritis.
    Pletikosic I; Marasovic Krstulovic D; Bakovic D; Susilovic Grabovac Z; Tandara L; Martinovic Kaliterna D
    Sci Rep; 2023 Jun; 13(1):10371. PubMed ID: 37365233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review.
    Dal Bello G; Gisondi P; Idolazzi L; Girolomoni G
    Rheumatol Ther; 2020 Jun; 7(2):271-285. PubMed ID: 32306243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment.
    Costa L; Ramonda R; Ortolan A; Favero M; Foti R; Visalli E; Rossato M; Cacciapaglia F; Lapadula G; Scarpa R
    Clin Rheumatol; 2019 Sep; 38(9):2355-2362. PubMed ID: 31264033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, metabolic syndrome and other comorbidities in rheumatoid arthritis and psoriatic arthritis: influence on disease activity and quality of life.
    Azevedo S; Santos-Faria D; Leite Silva J; Ramos Rodrigues J; Sousa Neves J; Peixoto D; Tavares-Costa J; Alcino S; Afonso C; Teixeira F
    Acta Reumatol Port; 2019; 44(4):322-324. PubMed ID: 32281967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register.
    Vieira-Sousa E; Eusébio M; Ávila-Ribeiro P; Khmelinskii N; Cruz-Machado R; Rocha TM; Bernardes M; Santos-Faria D; Silva JL; Santos H; Miguel C; Carvalho P; Costa T; Duarte AC; Meirinhos T; Nero P; Fonseca JE; Santos MJ
    J Rheumatol; 2020 May; 47(5):690-700. PubMed ID: 31371659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions.
    Xue Y; Jiang L; Cheng Q; Chen H; Yu Y; Lin Y; Yang X; Kong N; Zhu X; Xu X; Wan W; Zou H
    PLoS One; 2012; 7(10):e46740. PubMed ID: 23144698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis".
    Caso F; Postiglione L; Covelli B; Ricciardone M; Di Spigna G; Formisano P; D'Esposito V; Girolimetto N; Tasso M; Peluso R; Navarini L; Ciccozzi M; Margiotta DPE; Oliviero F; Afeltra A; Punzi L; Del Puente A; Scarpa R; Costa L
    Clin Rheumatol; 2019 Sep; 38(9):2547-2552. PubMed ID: 31147798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.
    Araujo EG; Englbrecht M; Hoepken S; Finzel S; Kampylafka E; Kleyer A; Bayat S; Schoenau V; Hueber A; Rech J; Schett G
    Semin Arthritis Rheum; 2019 Feb; 48(4):632-637. PubMed ID: 30037432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study.
    Schett G; Chen W; Gao S; Chakravarty SD; Shawi M; Lavie F; Zimmermann M; Sharaf M; Coates LC; Siebert S
    Arthritis Res Ther; 2023 Aug; 25(1):150. PubMed ID: 37587493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of obesity on autoimmune arthritis and its cardiovascular complications.
    Van Raemdonck K; Umar S; Szekanecz Z; Zomorrodi RK; Shahrara S
    Autoimmun Rev; 2018 Aug; 17(8):821-835. PubMed ID: 29885537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interleukin-17A inhibitor in Japanese patients with psoriatic arthritis compared with tumor necrosis factor-alpha inhibitor.
    Izumiyama T; Mori Y; Oizumi I; Hamada S; Kurishima H; Terui H; Omori-Shimada R; Yamasaki K; Itoi E
    J Orthop Surg (Hong Kong); 2021; 29(2):23094990211012286. PubMed ID: 33938296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of TNF-α inhibition
    Elliott A; Wright G; Pendleton A; Rooney M
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X231179524. PubMed ID: 38024204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.